Testicular cancer and Hodgkin's disease: Evaluation of semen quality

Human Reproduction

Volumn 18, Issue 4, 2003, Pages 796-801

  Gandini, Loredana ^a   Lombardo, Francesco ^a   Salacone, Pietro ^a   Paoli, Donatella ^a   Anselmo, Anna Paola ^b   Culasso, Franco ^b   Dondero, Franco ^a   Lenzi, Andrea ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hodgkin's disease; Semen quality; Testicular cancer

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; AZOOSPERMIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELL TYPE; CELL VOLUME; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; EJACULATION; EMBRYONAL CARCINOMA; ERYTHROCYTE SEDIMENTATION RATE; GONADOTROPIN BLOOD LEVEL; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; MEDICAL LITERATURE; MIXED TUMOR; NORMAL VALUE; ORCHIECTOMY; SEMEN ANALYSIS; SEMINOMA; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TESTIS CANCER;

EID: 0037385779     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg163     Document Type: Article

References (45)

1. Agarwal, A., Tolentino, M.V. Jr., Sidhu, R.S., Ayzman, I., Lee, J.C., Thomas, A.J. Jr. and Shekarriz, M. (1995) Effect of cryopreservation on semen quality in patients with testicular cancer. Urology, 46, 382-389.
2. Bahadur, G. (2000) Fertility issues for cancer patients. Mol. Cell. Endocrinol., 169, 117-122.
3. Barr, R.D., Clark, D.A. and Booth, J.D. (1993) Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder. Med. Hypoth., 40, 165-168.
4. Berthelsen, J.C. and Skakkebaek, N.E. (1983) Gonadal function in men with testis cancer. Fertil. Steril., 39, 68-72.
5. Boring, C.C. (1994) Cancer statistics, 1994. CA-Cancer J. Clin., 44, 7-26.
6. Botchan, A., Hauser, R., Yogev, L., Gamzu, R., Paz, G., Lessino, J.B. and Yavetz, H. (1997a) Testicular cancer and spermatogenesis. Hum. Reprod., 12, 755-758.
7. Botchan, A., Hauser, R., Gamzu, R., Yogev, L., Lessino, J.B., Paz, G. and Yavetz, H. (1997b) Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma. Hum. Reprod., 12, 73-76.
8. Carlsen, E., Giwercman, A., Keiding, N. and Skakkebaek, N.E. (1992) Evidence for decreasing quality of semen during last 50 years. Br. Med. J., 304, 609-613.
9. Dearnaley, D.P., Huddart, R.A. and Horwich, A. (2001) Managing testicular cancer. Br. Med. J., 322, 1583-1588.
10. De Kretser, D.M. (2000) Testicular cancer and infertility. Br. Med. J., 321, 781-782.
11. Depue, R.H., Pike, M.C. and Henderson, B.E. (1983) Estrogen exposure during gestation and risk of testicular cancer. J. Natl Cancer Inst., 71, 1151-1155.
12. Fitoussi, O., Eghbali, H., Tchen, N., Berjon, J.P., Soubeyran, P. and Hoerni, B. (2000) Semen analysis and cryopreservation before treatment in Hodgkin's disease. Ann. Oncol., 11, 679-684.
13. Fossa, S.D., Aass, N. and Molne, K. (1989) Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer? Br. J. Urol., 64, 524-529.
14. Fossa, S.D., Aabyholm, T., Vespestad, S., Norman, N. and Ous, S. (1993) Semen quality after treatment for testicular cancer. Eur. Urol., 23, 172-176.
15. Fritz, K. and Weissbach, L. (1985) Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil. Steril., 43, 451-454.
16. Gandini, L., Lombardo, F., Culasso, F., Dondero, F. and Lenzi, A. (2000a) Myth and reality of the decline in semen quality: An example of the relativity of data interpretation. J. Endocrinol. Invest., 23, 402-411.
17. Gandini, L., Lombardo, F., Paoli, D., Caponecchia, L., Familiari, F., Verlengia, C., Dondero, F. and Lenzi, A. (2000b) Study of apoptotic DNA fragmentation in human spermatozoa. Hum. Reprod., 15, 830-839.
18. Giwercman, A., Bruun, F., Frimodt-Möller, C. and Skakkebaek, N.E. (1989) Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J. Urol., 142, 998-1002.
19. Giwercman, A., Hopman, A.H., Ramaekers, F.C. and Skakkebaek, N.E. (1990) Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization. Am. J. Pathol., 136, 497-502.
20. Hayashi, T., Arai, G., Hyochi, N., Suzuki, M., Masuda, H., Kawakami, S., Okuno, T., Ishizaka, K., Kageyama, Y. and Kihara, K. (2001) Suppression of spermatogenesis in ipsilateral and contralateral testicular tissues in patients with seminoma by human chorionic gonadotropin beta subunit. Urology, 58, 251-257.
21. Hendry, W.F., Stedronska, J., Jones, C.R., Blackmore, C.A., Barrett, A. and Peckham, M.J. (1983) Semen analysis in testicular cancer and Hodgkin's disease: Pre- and post-treatment findings and implications for cryopreservation. Br. J. Urol., 55, 769-773.
22. Jacobsen, R., Bostofte, E., Engholm, E., Hansen, J., Olsen, J.H., Skakkebaek, N.E. and Moller, H. (2000) Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. Br. Med. J., 321, 789-792.
23. Jensen, T.K., Carlsen, E., Jorgensen, N., Berthelsen, J.G., Keiding, N., Christensen, K., Petersen, J.H., Knudsen, L.B. and Skakkebaek, N.E. (2002) Poor semen quality may contribute to recent decline in fertility rates. Hum. Reprod., 17, 1437-1440.
24. Kersemaekers, A.M., Van Weeren, P.C., Oosterhuis, J.W. and Looijenga, L.H. (2002) Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. J. Pathol., 196, 423-429.
25. Kliesch, S., Bergmann, M., Hertle, L., Nieschlag, E. and Behre, H.M. (1997) Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum. Reprod., 12, 2830-2835.
26. Laguna, M.P., Pizzocaro, G., Klepp, O., Algaba, F., Kisbenedek, L. and Leiva, O. (2001) EAU guidelines on testicular cancer. Eur. Urol., 40, 102-110.
27. Lampe, H., Horwich, A., Norman, A., Nicholls, J. and Dearnaley, D.P. (1997) Fertility after chemotherapy for testicular germ cell cancer. J. Clin. Oncol., 15, 39-245.
28. Marmor, D., Elefant, E., Dauchez, C. and Roux, C. (1986) Semen analysis in Hodgkin's disease before the onset of treatment. Cancer, 57, 1986-1987.
29. Meirow, D. and Schenker, J.G. (1995) Cancer and male infertility. Hum. Reprod., 10, 2017-2022.
30. Morrish, D.W., Venner, P.M., Siy, O., Barron, G., Bhardwaj, D. and Outhet, D. (1990) Mechanisms of endocrine dysfunction in patients with testicular cancer. J. Natl Cancer Inst., 82, 412-418.
31. Muller, J., Skakkebaek, N.E., Nielsen, O.H. and Graem, N. (1984) Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer, 54, 629-634.
32. Padron, O., Sharma, R.K., Thomas, A.J. and Agarwal, A. (1997) Effects of cancer on spermatozoa quality after cryopreservation: A 12-year experience. Fertil. Steril., 67, 326-331.
33. Panidis, D., Rousso, D., Stergiopoulos, K., Papathanasiou, K., Delkos, D. and Papaletsos, M. (1999) The effect of testicular seminoma in semen quality. Eur. J. Obstet. Gynecol. Reprod. Biol., 83, 219-222.
34. Petersen, P.M., Giwercman, A., Skakkebæk, N.E. and Rørth, M. (1998) Gonadal function in men with testicular cancer. Semin. Oncol., 25, 224-233.
35. Petersen, P.M., Giwercman, A., Hansen, S.W., Berthelsen, J.G., Daugaard, G., Rorth, M. and Skakkebaek, N.E. (1999) Impaired testicular function in patients with carcinoma-in-situ of the testis. J. Clin. Oncol., 17, 173-179.
36. Rueffer, U., Breuer, K., Josting, A., Lathan, B., Sieber, M., Manze, O., Grotenhermen, F.J., Tesch, H., Bredenfeld, H., Koch, P. et al. (2001) Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann. Oncol., 12, 1307-1311.
37. Salanova, M., Gandini, L., Lenzi, A., Chiarenza, C., Filippini, A., Dondero, F., Di Silverio, F. and Stefanini, M. (1999) Is hyperdiploidy of immature ejaculated germ cells predictive of testis malignancy? Lab. Invest., 79, 1127-1135.
38. Schrader, M., Muller, M., Straub, B. and Miller, K. (2001) The impact of chemotherapy on male fertility: A survey of the biologic basis and clinical aspects. Reprod. Toxicol., 15, 611-617.
39. Sharpe, R.M. and Skakkebaek, N.E. (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet, 341, 1392-1395.
40. Skakkebaek, N.E., Rajpert-De Meyts, E. and Jorgensen, N. (1998) Germ cell cancer and disorders of spermatogenesis: An environmental connection? APMIS, 106, 3-11.
41. Skakkebaek, N.E., Rajpert-De Meyts, E. and Main, K.M. (2001) Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum. Reprod., 16, 972-978.
42. Tal, R., Botchan, A., Hauser, R., Yogev, L., Paz, G. and Yavetz, H. (2000) Follow-up of sperm concentration and motility in patients with lymphoma. Hum. Reprod., 15, 1985-1988.
43. Viviani, S., Ragni, G., Santoro, A., Perotti, L., Cacciamo, E., Negretti, E., Valagussa, P. and Bonadonna, G. (1991) Testicular dysfunction in Hodgkin's disease before and after treatment. Eur. J. Cancer, 27, 1389-1392.
44. World Health Organization (1992) WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 3rd edn. Cambridge University Press, Cambridge.
45. World Health Organization (1999) WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 4th edn. Cambridge University Press, Cambridge.